K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar

K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar

<p><strong>Background</strong></p> Artemisinin-based combination therapy has been first-line treatment for falciparum malaria in Myanmar since 2005. The wide extent of artemisinin resistance in the Greater Mekong sub-region and the presence of mefloquine resistance at the Mya...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Win, AA, Imwong, M, Kyaw, MP, Woodrow, CJ, Chotivanich, K, Hanboonkunupakarn, B, Pukrittayakamee, S
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	BioMed Central 2016

Míreanna comhchosúla

Plasmodium falciparum pfmdr1 amplification, mefloquine resistance, and parasite fitness.
de réir: Preechapornkul, P, et al.
Foilsithe / Cruthaithe: (2009)

Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number.
de réir: Price, R, et al.
Foilsithe / Cruthaithe: (2004)

<it>Pfmdr1 </it>copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia
de réir: Wongsrichanalai Chansuda, et al.
Foilsithe / Cruthaithe: (2009-01-01)

Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria.
de réir: Mayxay, M, et al.
Foilsithe / Cruthaithe: (2001)

Low prevalence of copy number variation in pfmdr1 and pfpm2 in Plasmodium falciparum isolates from southern Angola
de réir: Denise Duarte, et al.
Foilsithe / Cruthaithe: (2025-01-01)

Identification of cryptic coinfection with Plasmodium falciparum in patients presenting with vivax malaria.
de réir: Mayxay, M, et al.
Foilsithe / Cruthaithe: (2001)

Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar
de réir: Kyaw, M, et al.
Foilsithe / Cruthaithe: (2013)

Efficacy of Artemether-Lumefantrine on various Plasmodium falciparum Kelch 13 and Pfmdr1 genes isolated in Ghana
de réir: Enoch Aninagyei, et al.
Foilsithe / Cruthaithe: (2020-11-01)

Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction
de réir: Awab, GR, et al.
Foilsithe / Cruthaithe: (2016)

Optimizing the culture of Plasmodium falciparum in hollow fiber bioreactors.
de réir: Preechapornkul, P, et al.
Foilsithe / Cruthaithe: (2010)

Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar.
de réir: Myat P Kyaw, et al.
Foilsithe / Cruthaithe: (2013-01-01)

No evidence of amplified Plasmodium falciparum plasmepsin II gene copy number in an area with artemisinin-resistant malaria along the China–Myanmar border
de réir: Fang Huang, et al.
Foilsithe / Cruthaithe: (2020-09-01)

Dual fluorescent labelling of the human malaria parasite <it>Plasmodium falciparum</it> for the analysis of the ABC type transporter <it>pfmdr2</it>
de réir: Rosental Benyamin, et al.
Foilsithe / Cruthaithe: (2012-11-01)

Epidemiology of Plasmodium vivax malaria infection in Nepal
de réir: Rijal, KR, et al.
Foilsithe / Cruthaithe: (2018)

Genetic diversity of Plasmodium falciparum populations in southeast and western Myanmar
de réir: Than Naing Soe, et al.
Foilsithe / Cruthaithe: (2017-07-01)

Polymorphisms in the Pfcrt, Pfmdr1, and Pfk13 genes of Plasmodium falciparum isolates from southern Brazzaville, Republic of Congo
de réir: Marcel Tapsou Baina, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Evidence for linkage of pfmdr1, pfcrt, and pfk13 polymorphisms to lumefantrine and mefloquine susceptibilities in a Plasmodium falciparum cross
de réir: Sean T. Windle, et al.
Foilsithe / Cruthaithe: (2020-12-01)

The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria.
de réir: Chotivanich, K, et al.
Foilsithe / Cruthaithe: (2000)

Artemisinin resistance in Plasmodium falciparum malaria.
de réir: Dondorp, A, et al.
Foilsithe / Cruthaithe: (2009)

pfmdr1 amplification is related to increased Plasmodium falciparum in vitro sensitivity to the bisquinoline piperaquine.
de réir: Veiga, M, et al.
Foilsithe / Cruthaithe: (2012)

Artemisinin resistance and malaria elimination: Where are we now?
de réir: Borimas Hanboonkunupakarn, et al.
Foilsithe / Cruthaithe: (2022-09-01)

Genetic analysis of the orthologous crt and mdr1 genes in Plasmodium malariae from Thailand and Myanmar
de réir: Pimpat, Y, et al.
Foilsithe / Cruthaithe: (2020)

Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan.
de réir: Awab, G, et al.
Foilsithe / Cruthaithe: (2013)

Prevalence of arps10, fd, pfmdr-2, pfcrt and pfkelch13 gene mutations in Plasmodium falciparum parasite population in Uganda.
de réir: Moses Ocan, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Molecular surveillance of pfcrt, pfmdr1 and pfk13-propeller mutations in Plasmodium falciparum isolates imported from Africa to China
de réir: Fang Huang, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria.
de réir: White, N, et al.
Foilsithe / Cruthaithe: (2014)

Role of different Pfcrt and Pfmdr-1 mutations in conferring resistance to antimalaria drugs in Plasmodium falciparum
de réir: Ibraheem, Zaid O., et al.
Foilsithe / Cruthaithe: (2014)

Balanced impacts of fitness and drug pressure on the evolution of PfMDR1 polymorphisms in Plasmodium falciparum
de réir: Marvin Duvalsaint, et al.
Foilsithe / Cruthaithe: (2021-06-01)

Cost effectiveness and resource allocation of Plasmodium falciparum malaria control in Myanmar: a modelling analysis of bed nets and community health workers
de réir: Drake, T, et al.
Foilsithe / Cruthaithe: (2015)

Polymorphonuclear leucocyte elastase in Plasmodium falciparum malaria.
de réir: Pukrittayakamee, S, et al.
Foilsithe / Cruthaithe: (1992)

Plasmodium falciparum Kelch 13 mutations and treatment response in patients in Hpa-Pun District, Northern Kayin State, Myanmar.
de réir: Bonnington, C, et al.
Foilsithe / Cruthaithe: (2017)

Spread of artemisinin resistance in Plasmodium falciparum malaria.
de réir: Ashley, E, et al.
Foilsithe / Cruthaithe: (2014)

Genetic analysis of the orthologous crt and mdr1 genes in Plasmodium malariae from Thailand and Myanmar
de réir: Yupawadee Pimpat, et al.
Foilsithe / Cruthaithe: (2020-08-01)

Genetic diversity of Plasmodium vivax and Plasmodium falciparum lactate dehydrogenases in Myanmar isolates
de réir: Jinyoung Lee, et al.
Foilsithe / Cruthaithe: (2020-02-01)

Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia
de réir: Elifaged Hailemeskel, et al.
Foilsithe / Cruthaithe: (2019-12-01)

A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand.
de réir: Pukrittayakamee, S, et al.
Foilsithe / Cruthaithe: (2010)

Cost of treating inpatient falciparum malaria on the Thai-Myanmar border
de réir: Kyaw, S, et al.
Foilsithe / Cruthaithe: (2014)

Artemisinin resistance and malaria elimination: where are we now?
de réir: Hanboonkunupakarn, B, et al.
Foilsithe / Cruthaithe: (2022)

The probability of a sequential Plasmodium vivax infection following asymptomatic Plasmodium falciparum and P. vivax infections in Myanmar, Vietnam, Cambodia, and Laos
de réir: Von Seidlein, L, et al.
Foilsithe / Cruthaithe: (2019)

In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1.
de réir: Mwai, L, et al.
Foilsithe / Cruthaithe: (2009)